BioHealth Capital Region

Xcellon Acquires 40,000 Sq ft Maryland Facility from NextCure to Deliver a cGMP-Ready CRDMO for ADCs

Xcellon Biologics, a Maryland CRDMO specializing in bioconjugates and complex biologics, has signed a definitive agreement to acquire the GMP biologics manufacturing facility built by NextCure, Inc. in Beltsville. The deal gives Xcellon its first cGMP capacity, completes the company’s transition from a development-stage CDMO into an end-to-end CRDMO, and puts a commissioned domestic bioconjugation […]